Lee, Soyoung http://orcid.org/0000-0002-4614-2931
Yu, Yong
Trimpert, Jakob http://orcid.org/0000-0003-1616-0810
Benthani, Fahad http://orcid.org/0000-0002-3283-307X
Mairhofer, Mario
Richter-Pechanska, Paulina
Wyler, Emanuel http://orcid.org/0000-0002-9884-1806
Belenki, Dimitri http://orcid.org/0000-0002-9004-9849
Kaltenbrunner, Sabine
Pammer, Maria
Kausche, Lea
Firsching, Theresa C. http://orcid.org/0000-0003-1378-4951
Dietert, Kristina
Schotsaert, Michael http://orcid.org/0000-0003-3156-3132
Martínez-Romero, Carles http://orcid.org/0000-0001-8888-7715
Singh, Gagandeep http://orcid.org/0000-0003-3260-2631
Kunz, Séverine http://orcid.org/0000-0002-0131-3506
Niemeyer, Daniela http://orcid.org/0000-0002-1897-6365
Ghanem, Riad
Salzer, Helmut J. F.
Paar, Christian
Mülleder, Michael
Uccellini, Melissa
Michaelis, Edward G.
Khan, Amjad
Lau, Andrea
Schönlein, Martin
Habringer, Anna
Tomasits, Josef
Adler, Julia M.
Kimeswenger, Susanne http://orcid.org/0000-0002-0443-8558
Gruber, Achim D. http://orcid.org/0000-0002-4502-0393
Hoetzenecker, Wolfram
Steinkellner, Herta
Purfürst, Bettina
Motz, Reinhard
Di Pierro, Francesco
Lamprecht, Bernd http://orcid.org/0000-0003-3365-3449
Osterrieder, Nikolaus
Landthaler, Markus http://orcid.org/0000-0002-1075-8734
Drosten, Christian http://orcid.org/0000-0001-7923-0519
García-Sastre, Adolfo http://orcid.org/0000-0002-6551-1827
Langer, Rupert
Ralser, Markus
Eils, Roland http://orcid.org/0000-0002-0034-4036
Reimann, Maurice
Fan, Dorothy N. Y.
Schmitt, Clemens A. http://orcid.org/0000-0002-4731-2226
Article History
Received: 10 January 2021
Accepted: 3 September 2021
First Online: 13 September 2021
Competing interests
: M.U. contributed to this Article as an employee of Mount Sinai and the views expressed do not necessarily represent the views of Regeneron Pharmaceuticals. F.D.P. is a member of the Scientific Board of Pharmextracta, the vendor of Quevir, a dietary supplement containing quercetin in a sunflower lecithin formulation. The laboratory of A.G.-S. has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, and Merck. A.G.-S. has consulting agreements with the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, and Pfizer. A.G.-S. is an inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections owned by the Icahn School of Medicine at Mount Sinai, New York. C.A.S. received travel support, honoraria and consulting fees from Abbvie, AstraZeneca, Bayer, Bristol-Myers Squibb/Celgene, Gilead/Kite, Janssen-Cilag, MSD, Novartis, Octapharma, Pierre Fabre, Roche, Sanofi, Takeda and TissUse.
Free to read: This content has been made available to all.